BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16496251)

  • 1. Resource use and costs for a glaucoma screening program in Austria: an 8-year review: a cost-consequence analysis based on the Salzburg-Moorfields Collaborative Glaucoma Study.
    Hitzl W; Ortner C; Hornykewycz K; Grabner G; Reitsamer HA
    Eur J Ophthalmol; 2006; 16(1):92-9. PubMed ID: 16496251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The projected increase in glaucoma due to the aging population in Austria from 2001 to 2031: results based on data of the Salzburg-Moorfields Collaborative Glaucoma Study.
    Hitzl W; Bunce C; Reitsamer HA; Grabner G; Hornykewycz K
    Eur J Ophthalmol; 2007; 17(1):45-52. PubMed ID: 17294382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany.
    Lorenz K; Wolfram C; Breitscheidel L; Shlaen M; Verboven Y; Pfeiffer N
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2019-28. PubMed ID: 23624617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Salzburg-Moorfields Collaborative Glaucoma Study: first results of the prevalence and 5-year incidences in this prospective, population-based longitudinal study].
    Hitzl W; Stöllinger M; Grabner G; Reitsamer HA; Hornykewycz K
    Klin Monbl Augenheilkd; 2006 Dec; 223(12):970-3. PubMed ID: 17199192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States.
    Kobelt-Nguyen G; Gerdtham UG; Alm A
    J Glaucoma; 1998 Apr; 7(2):95-104. PubMed ID: 9559495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the relationship between age and prevalence and/or incidence of primary open-angle glaucoma in the "Salzburg-Moorfields Collaborative Glaucoma Study"].
    Hitzl W; Hornykewycz K; Grabner G; Reitsamer HA
    Klin Monbl Augenheilkd; 2007 Feb; 224(2):115-9. PubMed ID: 17309007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of central corneal thickness in patients participating in a glaucoma screening programme and those who were examined in the glaucoma unit].
    Hufnagl C; Hitzl W; Hornykewycz K; Grabner G; Reitsamer HA
    Klin Monbl Augenheilkd; 2008 Feb; 225(2):151-4. PubMed ID: 18293267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of Technologies for Glaucoma Case-Finding in a Community Setting.
    Dabasia PL; Fidalgo BR; Edgar DF; Garway-Heath DF; Lawrenson JG
    Ophthalmology; 2015 Dec; 122(12):2407-15. PubMed ID: 26411836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Resource Use and Costs of Caring for Patients With Exfoliation Syndrome Glaucoma Versus Primary Open-Angle Glaucoma.
    Rathi S; Andrews C; Greenfield DS; Stein JD
    Am J Ophthalmol; 2019 Apr; 200():100-109. PubMed ID: 30629910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
    Lee PP; Walt JG; Doyle JJ; Kotak SV; Evans SJ; Budenz DL; Chen PP; Coleman AL; Feldman RM; Jampel HD; Katz LJ; Mills RP; Myers JS; Noecker RJ; Piltz-Seymour JR; Ritch RR; Schacknow PN; Serle JB; Trick GL
    Arch Ophthalmol; 2006 Jan; 124(1):12-9. PubMed ID: 16401779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients].
    Rouland JF; Peigne G; Sellem E; Renard JP; Williamson W; Filippi JM; Cohn H; Hamard P; Abellan P; Chagnon A; Malet F; Haye I
    J Fr Ophtalmol; 2001 Mar; 24(3):233-43. PubMed ID: 11285438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?
    Hagman J
    Acta Ophthalmol; 2013 May; 91 Thesis 3():1-47. PubMed ID: 23621767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist.
    Peeters A; Schouten JS; Webers CA; Prins MH; Hendrikse F; Severens JL
    Eye (Lond); 2008 Mar; 22(3):354-62. PubMed ID: 17128205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of glaucoma in Canada: analyses based on visual field and physician's assessment.
    Iskedjian M; Walker J; Vicente C; Trope GE; Buys Y; Einarson TR; Covert D
    J Glaucoma; 2003 Dec; 12(6):456-62. PubMed ID: 14646678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: Strategies, clinical outcomes, and costs at 2 years.
    Rouland JF; Le Pen C; Benhaddi H; Piriou E; Lilliu H; Kenigsberg PA;
    Eur J Ophthalmol; 2005; 15(5):562-80. PubMed ID: 16167287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term medical management of primary open-angle glaucoma and ocular hypertension in the UK: optimizing cost-effectiveness and clinic resources by minimizing therapy switches.
    Orme M; Collins S; Loftus J
    J Glaucoma; 2012 Sep; 21(7):433-49. PubMed ID: 21677590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
    Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D; Curry A; Evans SJ
    Acta Ophthalmol Scand; 2006 Feb; 84(1):74-83. PubMed ID: 16445443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk calculation variability over time in ocular hypertensive subjects.
    Song C; De Moraes CG; Forchheimer I; Prata TS; Ritch R; Liebmann JM
    J Glaucoma; 2014 Jan; 23(1):1-4. PubMed ID: 22668983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of newly diagnosed patients with glaucoma or with ocular hypertension in The Netherlands: an observational study of costs and initial treatment success based on retrospective chart review.
    Oostenbrink JB; Rutten-van Mölken MP; Opdenoordt TS
    Doc Ophthalmol; 1999; 98(3):285-99. PubMed ID: 10945448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.
    Salvetat ML; Zeppieri M; Tosoni C; Brusini P;
    Eye (Lond); 2016 Jun; 30(6):784-95. PubMed ID: 27174381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.